Mesothelioma

6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Neoplasms

Treatments and conditions

Mesothelioma
Treatment and conditionWhere it standsTrials
Navlimetostat for mesotheliomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Niraparib for mesotheliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Spartalizumab for mesotheliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for mesotheliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for mesotheliomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 Tablet and Pembrolizumab (200 mg) for mesotheliomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.